This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Dana-Farber-Cancer Institute Inc.. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Innovations by Antonio R Arulanandam
Introduction
Antonio R Arulanandam is a notable inventor based in Winchester, MA (US). He has made significant contributions to the field of immunology, particularly in the development of monoclonal antibodies. His work focuses on the HHLA2 receptor and its implications for therapeutic applications.
Latest Patents
Antonio holds a patent for "KIR3DL3 as an HHLA2 receptor, anti-HHLA2 antibodies, and uses thereof." This invention is based on the discovery of monoclonal antibodies and antigen-binding fragments that specifically bind to HHLA2. The patent outlines methods for using these antibodies for diagnostic, prognostic, and therapeutic purposes.
Career Highlights
Antonio is affiliated with the Dana-Farber Cancer Institute Inc., where he continues to advance research in cancer immunotherapy. His work has the potential to impact treatment strategies for various cancers, enhancing patient outcomes through innovative approaches.
Collaborations
Antonio collaborates with Gordon James Freeman, a respected figure in the field of cancer research. Their partnership aims to explore new avenues in immunotherapy and improve therapeutic options for patients.
Conclusion
Antonio R Arulanandam's contributions to the field of immunology and cancer research exemplify the impact of innovative thinking in medicine. His patent and ongoing work at the Dana-Farber Cancer Institute Inc. highlight the importance of advancements in therapeutic strategies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile